|
Doctorglasses Chain Co., Ltd. (300622.sz) Évaluation DCF
CN | Consumer Cyclical | Specialty Retail | SHZ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Doctorglasses Chain Co.,Ltd. (300622.SZ) Bundle
Vous cherchez à évaluer la valeur intrinsèque de Doctorglasses Chain Co., Ltd.? Notre calculatrice DCF (300622SZ) intègre des données du monde réel avec des fonctionnalités de personnalisation complètes, vous permettant d'affiner vos prévisions et d'améliorer vos décisions d'investissement.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 655.0 | 656.3 | 887.5 | 962.2 | 1,175.9 | 1,233.7 | 1,294.4 | 1,358.1 | 1,424.9 | 1,495.0 |
| Revenue Growth, % | 0 | 0.19542 | 35.22 | 8.42 | 22.2 | 4.92 | 4.92 | 4.92 | 4.92 | 4.92 |
| EBITDA | 87.9 | 98.1 | 267.3 | 279.0 | 314.5 | 281.9 | 295.7 | 310.3 | 325.5 | 341.6 |
| EBITDA, % | 13.42 | 14.95 | 30.12 | 28.99 | 26.74 | 22.85 | 22.85 | 22.85 | 22.85 | 22.85 |
| Depreciation | 28.3 | 33.8 | 163.0 | 173.7 | 166.2 | 148.1 | 155.4 | 163.0 | 171.1 | 179.5 |
| Depreciation, % | 4.33 | 5.14 | 18.37 | 18.05 | 14.13 | 12.01 | 12.01 | 12.01 | 12.01 | 12.01 |
| EBIT | 59.6 | 64.4 | 104.3 | 105.2 | 148.3 | 133.7 | 140.3 | 147.2 | 154.5 | 162.1 |
| EBIT, % | 9.1 | 9.81 | 11.75 | 10.94 | 12.61 | 10.84 | 10.84 | 10.84 | 10.84 | 10.84 |
| Total Cash | 320.2 | 413.7 | 265.5 | 226.0 | 193.5 | 448.5 | 470.6 | 493.8 | 518.0 | 543.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 28.2 | 36.9 | 46.3 | 48.7 | 103.5 | 71.6 | 75.1 | 78.8 | 82.6 | 86.7 |
| Account Receivables, % | 4.3 | 5.63 | 5.21 | 5.06 | 8.8 | 5.8 | 5.8 | 5.8 | 5.8 | 5.8 |
| Inventories | 89.4 | 92.3 | 133.0 | 161.8 | 174.4 | 183.4 | 192.5 | 201.9 | 211.9 | 222.3 |
| Inventories, % | 13.64 | 14.07 | 14.99 | 16.81 | 14.83 | 14.87 | 14.87 | 14.87 | 14.87 | 14.87 |
| Accounts Payable | 40.0 | 50.7 | 43.5 | 43.8 | 46.6 | 67.2 | 70.5 | 74.0 | 77.7 | 81.5 |
| Accounts Payable, % | 6.11 | 7.72 | 4.9 | 4.55 | 3.96 | 5.45 | 5.45 | 5.45 | 5.45 | 5.45 |
| Capital Expenditure | -55.6 | -25.8 | -43.5 | -26.3 | -21.6 | -54.0 | -56.6 | -59.4 | -62.4 | -65.4 |
| Capital Expenditure, % | -8.48 | -3.93 | -4.9 | -2.73 | -1.84 | -4.38 | -4.38 | -4.38 | -4.38 | -4.38 |
| Tax Rate, % | 21.97 | 21.97 | 21.97 | 21.97 | 21.97 | 21.97 | 21.97 | 21.97 | 21.97 | 21.97 |
| EBITAT | 44.5 | 51.9 | 81.6 | 85.9 | 115.7 | 105.2 | 110.4 | 115.8 | 121.5 | 127.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -60.2 | 58.8 | 143.8 | 202.6 | 195.6 | 242.9 | 199.9 | 209.7 | 220.0 | 230.9 |
| WACC, % | 5.36 | 5.37 | 5.36 | 5.37 | 5.36 | 5.36 | 5.36 | 5.36 | 5.36 | 5.36 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 946.2 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | 239 | |||||||||
| Terminal Value | 12,823 | |||||||||
| Present Terminal Value | 9,875 | |||||||||
| Enterprise Value | 10,821 | |||||||||
| Net Debt | -29 | |||||||||
| Equity Value | 10,850 | |||||||||
| Diluted Shares Outstanding, MM | 173 | |||||||||
| Equity Value Per Share | 62.70 |
Benefits You Will Enjoy
- Authentic Doctorglasses Financials: Access historical and projected data for precise valuation of (300622SZ).
- Customizable Inputs: Adjust parameters such as WACC, tax rates, sales growth, and capital investments.
- Dynamic Calculations: Get real-time assessments for intrinsic value and NPV.
- Comprehensive Scenario Analysis: Assess various scenarios to forecast the future performance of Doctorglasses.
- User-Friendly Design: Crafted for professionals while remaining approachable for newcomers.
Key Features
- Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for Doctorglasses Chain Co.,Ltd. (300622SZ).
- WACC Tool: Features a pre-built Weighted Average Cost of Capital sheet with adjustable parameters specific to the company.
- Customizable Forecast Inputs: Easily update growth projections, capital expenses, and discount rates.
- Integrated Financial Ratios: Assess profitability, leverage, and efficiency ratios relevant to Doctorglasses Chain Co.,Ltd. (300622SZ).
- Visual Dashboard and Charts: Provides graphical representations that encapsulate key valuation metrics for straightforward analysis.
How It Functions
- Download the Template: Gain immediate access to the Excel-based Doctorglasses DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for projected growth rates, WACC, profit margins, and more.
- Instant Calculations: The model automatically recalculates the intrinsic value of Doctorglasses Chain Co.,Ltd. (300622SZ).
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the outcomes to inform your investment or financial analyses.
Why Select This Calculator?
- Designed for Experts: A sophisticated tool favored by healthcare analysts, financial officers, and industry consultants.
- Accurate Data: Doctorglasses Chain Co., Ltd.'s historical and projected financials are preloaded for reliable results.
- Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Concise Outputs: Automatically computes intrinsic value, NPV, and other essential metrics.
- User-Friendly: Clear, step-by-step instructions lead you through each phase.
Who Should Use This Product?
- Individual Consumers: Make educated choices when purchasing eyewear from Doctorglasses Chain Co., Ltd. (300622SZ).
- Optical Retail Analysts: Enhance market analysis with readily available reports on Doctorglasses Chain Co., Ltd. (300622SZ).
- Consultants: Provide informed recommendations to clients regarding eyewear solutions offered by Doctorglasses Chain Co., Ltd. (300622SZ).
- Entrepreneurs in the Eyewear Sector: Gain insights into the valuation of companies like Doctorglasses Chain Co., Ltd. (300622SZ) to refine your business strategies.
- Students of Optometry and Business: Explore practical valuation methods using real data from Doctorglasses Chain Co., Ltd. (300622SZ).
Contents of the Template
- Operating and Balance Sheet Data: Pre-filled historical data and forecasts for Doctorglasses Chain Co., Ltd. (300622SZ), including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for the Weighted Average Cost of Capital (WACC), featuring parameters such as Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Customizable Discounted Cash Flow models that display intrinsic value along with comprehensive calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) provided to facilitate analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios specifically for Doctorglasses Chain Co., Ltd. (300622SZ).
- Dashboard and Charts: Visual representation of valuation results and assumptions for easy analysis of outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.